<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02165800</url>
  </required_header>
  <id_info>
    <org_study_id>CUSTOMER-001</org_study_id>
    <nct_id>NCT02165800</nct_id>
  </id_info>
  <brief_title>Multicenter Study on Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients</brief_title>
  <official_title>Multicenter Study on Outcomes and Protection of Urinary and Sexual Function of Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Third Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sixth Affiliated Hospital, Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Southern Medical University, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Third Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      TME (Total mesorectum excision) is the golden standard of radical resection for mid-low
      rectal cancer. However, the damage of pelvic autonomic nerve following with TME principle
      will lead to high incidence of urinary and sexual function disorder. Open PANP (pelvic
      autonomic nerve preservation) TME surgery played a role in decreasing incidence of urinary
      and sexual function disorder. However, 32%-44% patients still suffered from urinary and
      sexual function disorder when underwent Open PANP TME surgery (O-PANP-TME).

      Laparoscopy-assisted TME surgery (L-TME) is applied wildly nowadays. In the early stage of
      work, we performed laparoscopy-assisted PANP TME surgery (L-PANP-TME) to discuss the
      protection of urinary and sexual function of male mid-low rectal cancer patients. The results
      showed that L-PANP-TME significantly decreased incidence of urinary and sexual function
      disorder. In order to further confirm our early work, we design a multiple-center randomized
      controlled clinical trial to compare differences in urinary and sexual function protection
      and long-term outcomes between L-PANP-TME and O-PANP-TME.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>3-year disease free survival rate</measure>
    <time_frame>36 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urinary function</measure>
    <time_frame>30 days</time_frame>
    <description>Urodynamic study and IPSS (International prostate symptom score) are used to assess urinary function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sexual function</measure>
    <time_frame>30 days</time_frame>
    <description>IIEF-5 (International questionnaire of erectile function-5) and Ejaculation function classification are used to assess sexual function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>5-year disease free survival rate</measure>
    <time_frame>60 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urinary function</measure>
    <time_frame>36 months</time_frame>
    <description>Urodynamic study and IPSS (International prostate symptom score) are used to assess urinary function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sexual function</measure>
    <time_frame>36 months</time_frame>
    <description>IIEF-5 (International questionnaire of erectile function-5) and Ejaculation function classification are used to assess sexual function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3-year overall survival rate</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>5-year overall survival rate</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">667</enrollment>
  <condition>Rectum Neoplasms</condition>
  <arm_group>
    <arm_group_label>O-PANP-TME</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Open pelvic autonomic nerve preservation total mesorectum excision for male mid-low rectal cancer patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>L-PANP-TME</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopy-assisted pelvic autonomic nerve preservation total mesorectum excision for male mid-low rectal cancer patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>L-PANP-TME</intervention_name>
    <arm_group_label>L-PANP-TME</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>O-PANP-TME</intervention_name>
    <arm_group_label>O-PANP-TME</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age from over 20 to under 60 years

          -  Primary rectal adenocarcinoma confirmed pathologically by endoscopic biopsy

          -  Mid-low rectal cancer (distance from anal edgeâ‰¤12cm); cT1-3, N0-3, M0 at preoperative
             evaluation according to the AJCC Cancer Staging Manual Seventh Edition

          -  Expected curative resection through both L-PANP-TME and O-PANP-TME; Performance status
             of 0 or 1 on ECOG (Eastern Cooperative Oncology Group) scale

          -  ASA (American Society of Anesthesiology) score class I, II, or III; Written informed
             consent

          -  Urinary and sexual function normal preoperatively

        Exclusion Criteria:

          -  Women during pregnancy or breast-feeding

          -  Severe mental disorder

          -  History of previous pelvic surgery

          -  Enlarged or bulky regional lymph node diameter over 3cm by preoperative imaging

          -  History of other malignant disease within past five years

          -  History of unstable angina or myocardial infarction within past six months

          -  History of cerebrovascular accident within past six months

          -  History of continuous systematic administration of corticosteroids within one month

          -  Contraindication of heart, brain, lung, etc dysfunction

          -  Requirement of simultaneous surgery for other disease

          -  Emergency surgery due to complication (bleeding, obstruction or perforation) caused by
             rectal cancer

          -  Rectal cancer invades surrounding tissues

          -  Existence of genuine incontinence or severe stress incontinence preoperatively
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hongbo Wei, M.D,Ph.D.</last_name>
    <phone>+86-189-2210-2969</phone>
    <email>drweihb@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Third Affiliated Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510630</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongbo Wei, M.D., Ph.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2014</study_first_submitted>
  <study_first_submitted_qc>June 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2014</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Third Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Hongbo Wei</investigator_full_name>
    <investigator_title>Chief of surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

